Macquarie Group Ltd. lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.8% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 35,253 shares of the medical equipment provider’s stock after selling 1,000 shares during the period. Macquarie Group Ltd.’s holdings in Intuitive Surgical were worth $16,868,000 at the end of the most recent quarter.
Several other large investors have also bought and sold shares of ISRG. Adviser Investments LLC acquired a new position in shares of Intuitive Surgical during the second quarter worth about $115,000. Signet Financial Management LLC acquired a new position in Intuitive Surgical during the second quarter worth about $115,000. McKinley Carter Wealth Services Inc. acquired a new position in Intuitive Surgical during the first quarter worth about $132,000. Kaizen Advisory LLC grew its position in Intuitive Surgical by 156.0% during the second quarter. Kaizen Advisory LLC now owns 279 shares of the medical equipment provider’s stock worth $133,000 after buying an additional 170 shares during the period. Finally, Psagot Investment House Ltd. acquired a new position in Intuitive Surgical during the second quarter worth about $133,000. Institutional investors and hedge funds own 84.80% of the company’s stock.
Several brokerages have issued reports on ISRG. Morgan Stanley upped their price target on shares of Intuitive Surgical from $575.00 to $600.00 and gave the company an “overweight” rating in a report on Thursday. Piper Jaffray Companies raised shares of Intuitive Surgical from a “neutral” rating to an “overweight” rating and set a $600.00 price objective on the stock in a research note on Tuesday. Wells Fargo & Co upped their price objective on shares of Intuitive Surgical from $575.00 to $635.00 and gave the company an “outperform” rating in a research note on Wednesday, September 12th. BidaskClub downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, August 22nd. Finally, Citigroup upped their price objective on shares of Intuitive Surgical from $561.00 to $592.00 and gave the company a “buy” rating in a research note on Thursday, August 2nd. One research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have assigned a buy rating to the stock. Intuitive Surgical currently has an average rating of “Buy” and an average target price of $538.51.
ISRG traded up $23.80 during trading hours on Friday, reaching $532.02. 960,926 shares of the stock traded hands, compared to its average volume of 786,575. The firm has a market cap of $65.29 billion, a price-to-earnings ratio of 73.99, a PEG ratio of 4.20 and a beta of 0.89. Intuitive Surgical, Inc. has a fifty-two week low of $350.00 and a fifty-two week high of $581.12.
Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 19th. The medical equipment provider reported $2.76 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.02 by $0.74. The firm had revenue of $909.30 million for the quarter, compared to analysts’ expectations of $877.43 million. Intuitive Surgical had a net margin of 23.20% and a return on equity of 20.56%. Intuitive Surgical’s quarterly revenue was up 19.8% on a year-over-year basis. During the same quarter last year, the company earned $5.95 EPS. Analysts forecast that Intuitive Surgical, Inc. will post 9.31 earnings per share for the current year.
In other news, VP Marshall Mohr sold 8,250 shares of Intuitive Surgical stock in a transaction that occurred on Monday, July 30th. The shares were sold at an average price of $508.50, for a total value of $4,195,125.00. Following the transaction, the vice president now owns 18,071 shares of the company’s stock, valued at approximately $9,189,103.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Mark J. Rubash sold 350 shares of Intuitive Surgical stock in a transaction that occurred on Friday, August 31st. The stock was sold at an average price of $560.00, for a total transaction of $196,000.00. Following the completion of the transaction, the director now directly owns 4,316 shares in the company, valued at approximately $2,416,960. The disclosure for this sale can be found here. In the last three months, insiders have sold 109,463 shares of company stock worth $57,194,982. 2.20% of the stock is owned by corporate insiders.
About Intuitive Surgical
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Further Reading: Penny Stocks, What You Need To Know
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.